Results 351 to 360 of about 3,627,754 (377)

An update on larynx cancer

Ca-A Cancer Journal for Clinicians, 2017
Kristin A Higgins, Nabil F Saba
exaly  

Hepatosplenic T‐cell lymphoma, immunosuppressive agents and biologicals: what are the risks?

Internal medicine journal (Print), 2014
K. Subramaniam, D. Yeung, F. Grimpen, J. Joseph, K. Fay, M. Buckland, D. Talaulikar, J. Elijah, A. C. Clarke, P. Pavli, J. Moore   +10 more
semanticscholar   +1 more source

Nanooncology: The future of cancer diagnosis and therapy

Ca-A Cancer Journal for Clinicians, 2013
Sanjiv S Gambhir
exaly  

The current state of molecular testing in the treatment of patients with solid tumors, 2019

Ca-A Cancer Journal for Clinicians, 2019
Wafik S El-Deiry, Richard M Goldberg, Heinz-Josef Lenz   +2 more
exaly  

Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review

British Journal of Dermatology, 2013
J. Blok, S. V. Hattem, M. Jonkman, B. Horváth   +3 more
semanticscholar   +1 more source

Immunotherapy of cancer in 2012

Ca-A Cancer Journal for Clinicians, 2012
Lisa H Butterfield, Ahmad A Tarhini
exaly  

Anti-inflammatory and immunosuppressive agents in PAH.

Handbook of Experimental Pharmacology, 2013
J. Meloche, S. Renard, S. Provencher, S. Bonnet   +3 more
semanticscholar   +1 more source

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Fadlo R Khuri
exaly  

Systematic review: monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD

Gut, 2014
P. Dulai, C. Siegel, J. Colombel, W. Sandborn, L. Peyrin-Biroulet   +4 more
semanticscholar   +1 more source

Novel Agents on the Horizon for Cancer Therapy

Ca-A Cancer Journal for Clinicians, 2009
exaly